CD7 and acute lymphoblastic leukemia: CD7 is a transmembrane glycoprotein ubiquitously expressed on most T cells and NK cells and is particularly highly expressed in T-ALL and some PTCL subtypes, making it a key target for immunotherapy for T-cell malignancies.